These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30688558)

  • 1. Analgesic Effect of a Single Drop of Nepafenac 0.3% on Pain Associated with Intravitreal Injections: A Randomized Clinical Trial.
    Georgakopoulos CD; Plotas P; Kagkelaris K; Tsapardoni F; Makri OE
    J Ocul Pharmacol Ther; 2019 Apr; 35(3):168-173. PubMed ID: 30688558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections: A Randomized Crossover Study.
    Makri OE; Tsapardoni FN; Plotas P; Aretha D; Georgakopoulos CD
    Curr Eye Res; 2018 Aug; 43(8):1061-1064. PubMed ID: 29634375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diclofenac for pain associated with intravitreal injections: a prospective, randomized, placebo-controlled study.
    Makri OE; Tsapardoni FN; Pagoulatos DD; Pharmakakis N; Georgakopoulos CD
    Clin Exp Ophthalmol; 2017 Dec; 45(9):867-874. PubMed ID: 28508561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain Control after Intravitreal Injection Using Topical Nepafenac 0.3% or Pressure Patching: A Randomized, Placebo-Controlled Trial.
    Kaplan RI; Drinkwater OJ; Lee RH; Chod RB; Barash A; Giovinazzo JV; Gologorsky D; Jansen ME; Rosen RB; Gentile RC
    Ophthalmol Retina; 2019 Oct; 3(10):860-866. PubMed ID: 31221565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFFECT OF BROMFENAC ON PAIN RELATED TO INTRAVITREAL INJECTIONS: A Randomized Crossover Study.
    Georgakopoulos CD; Tsapardoni F; Makri OE
    Retina; 2017 Feb; 37(2):388-395. PubMed ID: 27442130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial.
    Colin J; Paquette B
    Clin Ther; 2006 Apr; 28(4):527-36. PubMed ID: 16750464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical nepafenac after intravitreal injection: a prospective double-masked randomized controlled trial.
    Ulrich JN
    Retina; 2014 Mar; 34(3):509-11. PubMed ID: 23928675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Tolerability of Diclofenac and Nepafenac.
    Achiron A; Karmona L; Mimouni M; Gershoni A; Dzhanov Y; Gur Z; Burgansky Z
    J Ocul Pharmacol Ther; 2016 Nov; 32(9):601-605. PubMed ID: 27513223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.
    Lane SS; Modi SS; Lehmann RP; Holland EJ
    J Cataract Refract Surg; 2007 Jan; 33(1):53-8. PubMed ID: 17189793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Trattler W; McDonald M
    Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nepafenac: new drug. After cataract surgery: just another NSAID eye drop. No better than other NSAID eye drops, and less convenient to use.
    Prescrire Int; 2009 Aug; 18(102):156. PubMed ID: 19743570
    [No Abstract]   [Full Text] [Related]  

  • 12. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
    Zaczek A; Artzen D; Laurell CG; Stenevi U; Montan P
    J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
    Maxwell WA; Reiser HJ; Stewart RH; Cavanagh HD; Walters TR; Sager DP; Meuse PA
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):593-9. PubMed ID: 19040348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 0.1% Nepafenac reduces pain and increases patient comfort during cataract surgery.
    Oğurel T; Oğurel R; Onaran Z; Örnek K
    Cont Lens Anterior Eye; 2018 Oct; 41(5):448-451. PubMed ID: 29807771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nepafenac Ophthalmic Suspension 0.3% for the Management of Ocular Pain After Photorefractive Keratectomy.
    Kontadakis GA; Chronopoulou KG; Tsopouridou R; Tabibian D; Kymionis GD
    J Refract Surg; 2018 Mar; 34(3):171-176. PubMed ID: 29522226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMPARISON OF THE EFFECTS OF EIGHT DIFFERENT TOPICAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ON REDUCING INTRAVITREAL INJECTION-INDUCED PAIN.
    SakallioĞlu AK; Kaya S; Garİp R; Güçlü H
    Retina; 2024 Jul; 44(7):1196-1202. PubMed ID: 38437826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.
    Warren KA; Fox JE
    Retina; 2008; 28(10):1427-34. PubMed ID: 18664937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy.
    Pollack A; Staurenghi G; Sager D; Mukesh B; Reiser H; Singh RP
    Br J Ophthalmol; 2017 Apr; 101(4):423-427. PubMed ID: 27388251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nepafenac eye drops on pain associated with pterygium surgery.
    Ozcimen M; Sakarya Y; Goktas S; Sakarya R; Yener HI; Bukus A; Demir LS
    Eye Contact Lens; 2015 May; 41(3):187-9. PubMed ID: 25603438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of topical nepafenac on corneal epithelial healing time and postoperative pain after PRK: a bilateral, prospective, randomized, masked trial.
    Caldwell M; Reilly C
    J Refract Surg; 2008 Apr; 24(4):377-82. PubMed ID: 18500088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.